What is the recommended treatment for a 78-year-old woman with a Candida glabrata Urinary Tract Infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Candida glabrata UTI in a 78-year-old Woman

For a 78-year-old woman with Candida glabrata urinary tract infection, oral fluconazole is not recommended as first-line therapy due to frequent resistance; instead, treatment should begin with removal of any urinary catheter if present, followed by an echinocandin such as caspofungin 70mg loading dose then 50mg daily for 14 days. 1, 2

Initial Management Steps

  1. Remove predisposing factors:

    • Remove indwelling bladder catheter if present (resolves candiduria in ~50% of cases)
    • Correct any urinary tract obstruction
    • Replace or remove nephrostomy tubes/stents if present
    • Ensure adequate hydration 2
  2. Diagnostic confirmation:

    • Obtain urine culture to confirm C. glabrata and determine susceptibility
    • Order blood cultures to rule out candidemia, especially if fever is present
    • Complete metabolic panel to assess renal function 2

Antifungal Therapy Options

First-line Treatment

For C. glabrata UTI (which is often fluconazole-resistant):

  • Echinocandin therapy (despite limited urinary concentrations, effective for tissue invasion):
    • Caspofungin: 70mg IV loading dose, then 50mg IV daily for 14 days 1, 3
    • Micafungin: 150mg IV daily for 14 days 2, 4
    • Anidulafungin: 200mg IV loading dose, then 100mg IV daily for 14 days 1

Alternative Options

If echinocandins cannot be used or for less severe infections:

  • Amphotericin B deoxycholate: 0.3-0.6 mg/kg IV daily for 1-7 days 2
  • Flucytosine: 25 mg/kg orally 4 times daily for 7-10 days 2
  • Intravaginal boric acid: 600mg daily for 14 days (if vulvovaginal involvement) 1

Special Considerations for C. glabrata

  1. Resistance patterns:

    • C. glabrata frequently shows reduced susceptibility to fluconazole
    • Echinocandins are preferred despite suboptimal urinary concentrations due to tissue penetration 4
  2. Treatment duration:

    • Minimum 14 days of therapy
    • Continue until symptoms resolve and urine cultures become negative 2
  3. Monitoring:

    • Follow-up urine cultures to confirm eradication
    • Monitor renal function, especially in elderly patients
    • Assess for clinical improvement of symptoms 2

Management of Complications

  1. Fungus ball formation:

    • Surgical or endoscopic removal is central to successful treatment
    • Consider irrigation through nephrostomy tubes with amphotericin B if present 1, 2
  2. Persistent infection:

    • Consider imaging to rule out anatomical abnormalities
    • Evaluate for underlying immunosuppression
    • Consider combination therapy in refractory cases 2

Pitfalls and Caveats

  • Do not use fluconazole as first-line therapy for C. glabrata UTI due to frequent resistance
  • Do not leave urinary catheters in place during treatment as they serve as a nidus for infection
  • Do not assume treatment failure too early - clinical response may take several days
  • Avoid unnecessary treatment of asymptomatic candiduria in non-high-risk patients
  • Remember that echinocandins achieve poor urinary concentrations but are still effective for tissue invasion in C. glabrata infections 2, 5, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Fungal Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of candiduria with micafungin: A case series.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2007

Research

Candida urinary tract infections: treatment options.

Expert review of anti-infective therapy, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.